TCG Crossover Management

TCG Crossover Management as of June 30, 2022

Portfolio Holdings for TCG Crossover Management

TCG Crossover Management holds 22 positions in its portfolio as reported in the June 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Cogent Biosciences Common Stock (COGT) 13.3 $31M 3.5M 9.02
Iveric Bio Common Stock 11.9 $28M 2.9M 9.62
Geron Corporation Common Stock (GERN) 9.9 $23M 15M 1.55
Kura Oncology Common Stock (KURA) 9.1 $21M 1.2M 18.33
CymaBay Therapeutics Common Stock 7.4 $17M 5.9M 2.95
Aclaris Therapeuitics Common Stock (ACRS) 6.8 $16M 1.1M 13.96
Viridian Therapeutics Common Stock (VRDN) 6.5 $15M 1.3M 11.57
Chinook Therapeutics Common Stock 5.9 $14M 797k 17.49
Aerovate Therapeutics Common Stock (AVTE) 5.9 $14M 890k 15.63
Entrada Therapeutics Common Stock (TRDA) 3.4 $8.1M 664k 12.18
Merus Common Stock (MRUS) 2.9 $6.8M 300k 22.64
Tyra Biosciences Common Stock (TYRA) 2.7 $6.4M 896k 7.15
Akouos Common Stock 2.7 $6.3M 1.4M 4.69
Tango Therapeutics Common Stock (TNGX) 2.3 $5.3M 1.2M 4.53
MoonLake Immunotherapeutics Common Stock (MLTX) 2.2 $5.3M 1.0M 5.25
Alpine Immune Sciences Common Stock 2.1 $4.9M 578k 8.51
89bio Common Stock (ETNB) 1.6 $3.6M 1.1M 3.22
Zai Lab LTD- Common Stock (ZLAB) 1.4 $3.3M 95k 34.68
Magenta Therapeutics Common Stock 1.1 $2.5M 2.1M 1.20
AnaptysBio Common Stock (ANAB) 0.5 $1.2M 59k 20.30
Elevation Oncology Common Stock (ELEV) 0.3 $777k 555k 1.40
Pardes Biosciences Common Stock 0.1 $181k 59k 3.07